+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Leukemia"

From
From
From
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market 2023-2027 - Product Thumbnail Image

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market 2023-2027

  • Report
  • February 2023
  • 166 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Treatment Market in APAC 2022-2026 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Treatment Market in APAC 2022-2026

  • Report
  • February 2022
  • 120 Pages
  • Asia Pacific
From
From
From
From
From
From
From
From
Haematology Diagnostics Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Haematology Diagnostics Market - Forecasts from 2022 to 2027

  • Report
  • April 2022
  • 121 Pages
  • Global
From
Loading Indicator

Leukemia is a type of cancer that affects the blood and bone marrow. It is a form of hematological malignancy, which is a cancer of the blood-forming cells. Leukemia is characterized by an abnormal increase in the number of white blood cells in the body, which can interfere with the normal functioning of the blood and bone marrow. Symptoms of leukemia can include fatigue, fever, anemia, and an enlarged spleen. Treatment for leukemia typically involves chemotherapy, radiation therapy, and/or stem cell transplantation. There are several companies that are involved in the Leukemia market. These include pharmaceutical companies such as Novartis, Celgene, and Bristol-Myers Squibb, as well as biotechnology companies such as Gilead Sciences and Amgen. Additionally, there are a number of research organizations and academic institutions that are actively researching new treatments for leukemia. Show Less Read more